RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Reporting results of cancer treatment

1981 • 7,916 citations

Analysis of Binary Data

2008 • 2,760 citations

International Histological Classification of Tumours

1981 • 2,045 citations

Histological Typing of Ovarian Tumours

1999 • 668 citations

Advanced Ovarian Adenocarcinoma

1978 • 324 citations

Management of Ovarian Carcinoma

1976 • 154 citations

Wenckebach A-V block: A frequent feature following heavy physical training

1975 • 138 citations

Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.

1982 • 137 citations

Management of Ovarian Carcinoma

1976 • 121 citations

Advanced ovarian cancer correlation of histologic grade with response to therapy and survival

1980 • 116 citations

Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin

1981 • 113 citations

Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.

1979 • 105 citations

Epithelial Carcinoma of the Ovary: Current Strategies

1981 • 97 citations

F.I.G.O. NEWS

1971 • 93 citations

Second trial drugs in ovarian cancer

1977 • 88 citations

Chemotherapy of ovarian cancer: past and present.

1975 • 84 citations

The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).

1979 • 71 citations

International Histological Classification of Tumours, No. 9. Histological Typing of Ovarian Tumours

1974 • 58 citations

Wenckebach atrioventricular block (Mobitz type I) in children and adolescents

1977 • 56 citations

Hexamethylmelamine: An evaluation of its role in the treatment of ovarian cancer

1979 • 54 citations

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

1981 • 53 citations

Single-agent cis-platinum therapy for advanced ovarian cancer.

1981 • 46 citations

Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.

1975 • 30 citations

Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas

1980 • 28 citations

Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer

1984 • 26 citations

Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.

1977 • 22 citations

cis-Platinum in gynecologic cancer

1981 • 19 citations

Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.

1980 • 15 citations

Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma

1984 • 12 citations

Therapy of Advanced Ovarian Carcinoma

1979 • 6 citations

Long Term Survival Following Chemotherapy for Advanced Epithelial Ovarian Carcinoma

1980 • 5 citations